- Home
- AGM vs IBRX Comparison
AGM vs IBRX Comparison
Compare AGM & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGM
- IBRX
- Stock Information
- Founded
- AGM 1987
- IBRX 2014
- Country
- AGM United States
- IBRX United States
- Employees
- AGM N/A
- IBRX N/A
- Industry
- AGM Finance Companies
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGM Finance
- IBRX Health Care
- Exchange
- AGM Nasdaq
- IBRX Nasdaq
- Market Cap
- AGM 2.3B
- IBRX 2.3B
- IPO Year
- AGM N/A
- IBRX N/A
- Fundamental
- Price
- AGM $196.78
- IBRX $2.60
- Analyst Decision
- AGM Hold
- IBRX Strong Buy
- Analyst Count
- AGM 1
- IBRX 6
- Target Price
- AGM $217.00
- IBRX $9.83
- AVG Volume (30 Days)
- AGM 73.5K
- IBRX 9.0M
- Earning Date
- AGM 11-03-2025
- IBRX 11-11-2025
- Dividend Yield
- AGM 3.04%
- IBRX N/A
- EPS Growth
- AGM 3.61
- IBRX N/A
- EPS
- AGM 16.97
- IBRX N/A
- Revenue
- AGM $368,431,000.00
- IBRX $56,600,000.00
- Revenue This Year
- AGM $12.46
- IBRX $629.94
- Revenue Next Year
- AGM $8.69
- IBRX $109.91
- P/E Ratio
- AGM $11.62
- IBRX N/A
- Revenue Growth
- AGM 2.95
- IBRX 4227.22
- 52 Week Low
- AGM $159.64
- IBRX $1.83
- 52 Week High
- AGM $217.14
- IBRX $7.48
- Technical
- Relative Strength Index (RSI)
- AGM 50.22
- IBRX 59.00
- Support Level
- AGM $195.00
- IBRX $2.32
- Resistance Level
- AGM $209.18
- IBRX $2.67
- Average True Range (ATR)
- AGM 3.86
- IBRX 0.12
- MACD
- AGM -1.64
- IBRX 0.04
- Stochastic Oscillator
- AGM 12.52
- IBRX 84.09
About AGM Federal Agricultural Mortgage Corporation
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.